CompuMed Valuation

CMPD Stock  USD 3.27  0.48  12.80%   
At this time, the firm appears to be overvalued. CompuMed shows a prevailing Real Value of $2.87 per share. The current price of the firm is $3.27. Our model approximates the value of CompuMed from analyzing the firm fundamentals such as Current Valuation of 4.12 M, profit margin of (0.02) %, and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
3.27
Please note that CompuMed's price fluctuation is very risky at this time. Calculation of the real value of CompuMed is based on 3 months time horizon. Increasing CompuMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CompuMed pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CompuMed. Since CompuMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CompuMed Pink Sheet. However, CompuMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.27 Real  2.87 Hype  3.27 Naive  3.7
The real value of CompuMed Pink Sheet, also known as its intrinsic value, is the underlying worth of CompuMed Company, which is reflected in its stock price. It is based on CompuMed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CompuMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
2.87
Real Value
9.44
Upside
Estimating the potential upside or downside of CompuMed helps investors to forecast how CompuMed pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CompuMed more accurately as focusing exclusively on CompuMed's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.393.324.26
Details
Hype
Prediction
LowEstimatedHigh
0.163.279.84
Details
Naive
Forecast
LowNext ValueHigh
0.073.7010.26
Details

CompuMed Total Value Analysis

CompuMed is currently projected to have valuation of 4.12 M with market capitalization of 4.12 M, debt of 24.91 K, and cash on hands of 4 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CompuMed fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
4.12 M
4.12 M
24.91 K
K

CompuMed Investor Information

The company recorded a loss per share of 0.01. CompuMed had not issued any dividends in recent years. The entity had 1:25 split on the 23rd of May 2022. Based on the measurements of operating efficiency obtained from CompuMed's historical financial statements, CompuMed is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

CompuMed Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CompuMed has an asset utilization ratio of 276.18 percent. This indicates that the Company is making $2.76 for each dollar of assets. An increasing asset utilization means that CompuMed is more efficient with each dollar of assets it utilizes for everyday operations.

CompuMed Profitability Analysis

The company reported the previous year's revenue of 2.31 M. Net Income was 84.95 K with profit before overhead, payroll, taxes, and interest of 879 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CompuMed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CompuMed and how it compares across the competition.

About CompuMed Valuation

The pink sheet valuation mechanism determines CompuMed's current worth on a weekly basis. Our valuation model uses a comparative analysis of CompuMed. We calculate exposure to CompuMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CompuMed's related companies.
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.

8 Steps to conduct CompuMed's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CompuMed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CompuMed's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain CompuMed's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine CompuMed's revenue streams: Identify CompuMed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research CompuMed's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish CompuMed's growth potential: Evaluate CompuMed's management, business model, and growth potential.
  • Determine CompuMed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CompuMed's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for CompuMed Pink Sheet analysis

When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope